Market News AIOpen the app

NRSN stock news · NeuroSense Therapeutics Ltd.

Stories about NeuroSense Therapeutics Ltd. (NRSN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for NRSN

Follow NeuroSense Therapeutics Ltd. (NRSN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for NRSN
Free on the App Store and Google Play, or on the web.
  1. Oct 30, 2026, 3:26 AM ET · Market

    NeuroSense will show new clinical and biomarker data for its ALS treatment at the NEALS 2026 conference.

    Neutral

    NeuroSense plans to present new clinical and biomarker findings on PrimeC at NEALS 2026. Since the release shares no results, it does not change the company's prospects.

  2. Oct 19, 2026, 1:17 PM ET · Market

    12 health care companies are seeing big changes in their stock prices today.

    Neutral

    The article reports a fall in NeuroSense Therapeutics shares but gives no company news explaining it. The share move alone does not change what the article says about the company.

  3. Oct 13, 2026, 5:12 PM ET · Market

    12 health care stocks changed a lot in prices after the market closed on Tuesday.

    Neutral

    NeuroSense Therapeutics shares fell about 17% after hours. The article gives no business reason for the move, so it does not change what we know about the company.